What is Northland Capmk’s Estimate for CVE:HIV Q3 Earnings?

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities researchers at Northland Capmk increased their Q3 2026 earnings per share (EPS) estimates for HIVE Blockchain Technologies in a research report issued on Wednesday, January 29th. Northland Capmk analyst M. Grondahl now anticipates that the company will post earnings per share of $0.11 for the quarter, up from their prior forecast of $0.07.

Several other research analysts have also weighed in on HIV. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Finally, Roth Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Wednesday, December 18th. Four analysts have rated the stock with a strong buy rating, According to data from MarketBeat, HIVE Blockchain Technologies has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies (CVE:HIV) last posted its quarterly earnings data on Tuesday, November 12th. The company reported C($0.08) EPS for the quarter, beating analysts’ consensus estimates of C($0.12) by C$0.04. During the same period last year, the business posted ($0.39) EPS.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.